Valuation: BELE LIFEPAR

Market Cap 46.6M 41.36M 38.71M 35.08M 66.26M 4.49B 66.74M 465M 181M 2.29B 175M 171M 7.37B P/E 2022 *
-
P/E 2023 210x
Enterprise Value 46.65M 41.41M 38.75M 35.13M 66.34M 4.5B 66.82M 465M 181M 2.29B 175M 171M 7.38B EV / Sales 2022 *
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -
1 day-8.64%
Current month-92.69%
Current year-92.69%
3 years 0.2
Extreme 0.2
13.4
5 years 0.2
Extreme 0.2
13.4
10 years 0.2
Extreme 0.2
13.4

Financials

2022 2023
Net sales - -
Net income -35.39K -31.41K -29.4K -26.65K -50.32K -3.41M -50.69K -353K -137K -1.74M -133K -130K -5.59M 404K 358K 335K 304K 574K 38.92M 578K 4.03M 1.57M 19.86M 1.52M 1.48M 63.83M
Net Debt 1.09M 970K 908K 823K 1.55M 105M 1.56M 10.9M 4.24M 53.73M 4.1M 4.01M 173M 56.58K 50.23K 47K 42.6K 80.46K 5.45M 81.04K 565K 220K 2.78M 212K 208K 8.95M
Projected Income Statement - Annual - BELE LIFEPAR
Logo BELE LIFEPAR
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.
Employees
-
Sector
-
Date Price Change
06/10/26 US$0.2200 -8.64%
05/10/26 US$0.2408 +0.33%
02/10/26 US$0.2400 -2.83%
01/10/26 US$0.2470 -8.52%
30/09/26 US$0.2700 +30.06%
  1. Stock Market
  2. Stocks
  3. BLAC Stock